0001415889-22-006386.txt : 20220609
0001415889-22-006386.hdr.sgml : 20220609
20220609165750
ACCESSION NUMBER: 0001415889-22-006386
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220607
FILED AS OF DATE: 20220609
DATE AS OF CHANGE: 20220609
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEVINE ARNOLD J
CENTRAL INDEX KEY: 0001124164
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38520
FILM NUMBER: 221006633
MAIL ADDRESS:
STREET 1: C/O JAN STERN REED BAXTER INTERNATIONAL
STREET 2: ONE BAXTER PARKWAY DF2 2W
CITY: DEERFIELD
STATE: IL
ZIP: 60015
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MeiraGTx Holdings plc
CENTRAL INDEX KEY: 0001735438
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 450 EAST 29TH STREET
STREET 2: 15TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 6464902965
MAIL ADDRESS:
STREET 1: 450 EAST 29TH STREET
STREET 2: 15TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
4
1
form4-06092022_010640.xml
X0306
4
2022-06-07
0001735438
MeiraGTx Holdings plc
MGTX
0001124164
LEVINE ARNOLD J
450 EAST 29TH STREET
14TH FLOOR
NEW YORK
NY
10016
true
false
false
false
Stock Option (right to buy)
8.25
2022-06-07
4
A
0
15000
0
A
2032-06-07
Ordinary Shares
15000
15000
D
Restricted Share Units
2022-06-07
4
A
0
15000
0
A
Ordinary Shares
15000
15000
D
The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 7, 2023 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2023.
Each restricted share unit converts into one ordinary share upon settlement. The reporting person elected to have the restricted share units become settleable when the reporting person ceases to be a director.
The restricted share units shall vest in a single annual installment upon the earlier of (i) June 7, 2023 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2023.
/s/ Richard Giroux, Attorney-in-Fact for Arnold J. Levine
2022-06-09